Anti-inflammatory effects of luteolin: A review of in vitro, in vivo, and in silico studies

Journal of Ethnopharmacology

Volumn 225, Issue , 2018, Pages 342-358

  Aziz, Nur ^a   Kim, Mi Yeon ^b   Cho, Jae Youl ^a  

^a Sungkyunkwan University   (South Korea)

^b Soongsil University   (South Korea)

Author keywords

Flavonoid; Inflammatory diseases; Inflammatory signaling; Luteolin; Luteolin (PubChem CID: 5280445); Luteolin 5 O glucoside (PubChem CID: 44258061); Luteolin 6 C glucoside (PubChem CID: 49852298); Luteolin 7 O glucoside (PubChem CID: 5280637); Luteolin 8 C glucoside (PubChem CID: 5281675)

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; LUTEOLIN; LUTEOLIN 7 GLUCOSIDE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; SRC PROTEIN TYROSINE KINASE; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT;

ANTIINFLAMMATORY ACTIVITY; BIOLOGICAL ACTIVITY; COMPUTER MODEL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; JAK-STAT SIGNALING; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; THERAPY EFFECT; ANIMAL; COMPUTER SIMULATION; DRUG EFFECT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; COMPUTER SIMULATION; HUMANS; LUTEOLIN; SIGNAL TRANSDUCTION;

EID: 85047256115     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2018.05.019     Document Type: Review

References (115)

1. Abdallah, H.M., Esmat, A., Antioxidant and anti-inflammatory activities of the major phenolics from Zygophyllum simplex L. J. Ethnopharmacol. 205 (2017), 51–56.
2. Akram, M., Syed, Ahmed S., Kim, K.-A., Lee, Jong, S., Chang, S.-Y., Kim, Chul Y., Bae, O.-N., Heme oxygenase 1-mediated novel anti-inflammatory activities of Salvia plebeia and its active components. J. Ethnopharmacol. 174 (2015), 322–330.
3. Ando, C., Takahashi, N., Hirai, S., Nishimura, K., Lin, S., Uemura, T., Goto, T., Yu, R., Nakagami, J., Murakami, S., Kawada, T., Luteolin, a food-derived flavonoid, suppresses adipocyte-dependent activation of macrophages by inhibiting JNK activation. FEBS Lett. 583 (2009), 3649–3654.
4. Araujo, J.A., Zhang, M., Yin, F., Heme oxygenase-1, oxidation, inflammation, and atherosclerosis. Front. Pharmacol., 3, 2012, 119.
5. Azab, A., Nassar, A., Azab, A., Anti-inflammatory activity of natural products. Molecules, 21, 2016, 1321.
6. Backhouse, N., Rosales, L., Apablaza, C., Goïty, L., Erazo, S., Negrete, R., Theodoluz, C., Rodríguez, J., Delporte, C., Analgesic, anti-inflammatory and antioxidant properties of Buddleja globosa, Buddlejaceae. J. Ethnopharmacol. 116 (2008), 263–269.
7. Baek, K.S., Yi, Y.S., Son, Y.J., Yoo, S., Sung, N.Y., Kim, Y., Hong, S., Aravinthan, A., Kim, J.H., Cho, J.Y., In vitro and in vivo anti-inflammatory activities of Korean Red Ginseng-derived components. J. Ginseng Res. 40 (2016), 437–444.
8. Baek, K.S., Yi, Y.S., Son, Y.J., Jeong, D., Sung, N.Y., Aravinthan, A., Kim, J.H., Cho, J.Y., Comparison of anticancer activities of Korean red ginseng-derived fractions. J. Ginseng Res. 41 (2017), 386–391.
9. Chen, D., Bi, A., Dong, X., Jiang, Y., Rui, B., Liu, J., Yin, Z., Luo, L., Luteolin exhibits anti-inflammatory effects by blocking the activity of heat shock protein 90 in macrophages. Biochem. Biophys. Res. Commun. 443 (2014), 326–332.
10. Chen, S., Guo, J., Feng, C., Ke, Z., Chen, L., Pan, Y., The preoperative platelet-lymphocyte ratio versus neutrophil-lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma?. Ther. Adv. Med. Oncol. 8 (2016), 160–167.
11. Chen, Z., Chen, M., Pan, H., Sun, S., Li, L., Zeng, S., Jiang, H., Role of catechol-O-methyltransferase in the disposition of luteolin in rats. Drug. Metab. Dispos. 39 (2011), 667–674.
12. Choi, E.M., Lee, Y.S., Luteolin suppresses IL-1beta-induced cytokines and MMPs production via p38 MAPK, JNK, NF-kappaB and AP-1 activation in human synovial sarcoma cell line, SW982. Food Chem. Toxicol. 48 (2010), 2607–2611.
13. Choi, J.S., Islam, M.N., Ali, M.Y., Kim, Y.M., Park, H.J., Sohn, H.S., Jung, H.A., The effects of C-glycosylation of luteolin on its antioxidant, anti-Alzheimer's disease, anti-diabetic, and anti-inflammatory activities. Arch. Pharm. Res. 37 (2014), 1354–1363.
14. Choi, M.R., Kwak, S.M., Bang, S.H., Jeong, J.E., Kim, D.J., Chronic saponin treatment attenuates damage to the pancreas in chronic alcohol-treated diabetic rats. J. Ginseng Res. 41 (2017), 503–512.
15. Cock, I.E., Problems of reproducibility and efficacy of bioassays using crude extracts, with reference to Aloe vera. Phcog. Commun. 1 (2011), 52–62.
16. Costa, G., Ferreira, J.P., Vitorino, C., Pina, M.E., Sousa, J.J., Figueiredo, I.V., Batista, M.T., Polyphenols from Cymbopogon citratus leaves as topical anti-inflammatory agents. J. Ethnopharmacol. 178 (2016), 222–228.
17. da Silva, L.M., Farias, J.A., Boeing, T., Somensi, L.B., Beber, A.P., Cury, B.J., Santin, J.R., Faloni de Andrade, S., Hydroalcoholic extract from inflorescences of Achyrocline satureioides (Compositae) ameliorates dextran sulphate sodium-induced colitis in mice by attenuation in the production of inflammatory cytokines and oxidative mediators. Evid. Based Complement. Altern. Med., 2016, 2016, 3475356.
18. Dash, R., Uddin, M.M.N., Hosen, S.M.Z., Rahim, Z.B., Dinar, A.M., Kabir, M.S.H., Sultan, R.A., Islam, A., Hossain, M.K., Molecular docking analysis of known flavonoids as duel COX-2 inhibitors in the context of cancer. Bioinformation 11 (2015), 543–549.
19. de Souza, M.R., de Paula, C.A., Pereira de Resende, M.L., Grabe-Guimarães, A., de Souza Filho, J.D., Saúde-Guimarães, D.A., Pharmacological basis for use of Lychnophora trichocarpha in gouty arthritis: anti-hyperuricemic and anti-inflammatory effects of its extract, fraction and constituents. J. Ethnopharmacol. 142 (2012), 845–850.
20. 2+ signals contribute to wrong decisions for chronic lymphocytic leukemic B lymphocyte outcome?. Int. J. Dev. Biol. 59 (2015), 379–389.
21. Deqiu, Z., Kang, L., Jiali, Y., Baolin, L., Gaolin, L., Luteolin inhibits inflammatory response and improves insulin sensitivity in the endothelium. Biochimie 93 (2011), 506–512.
22. Domitrovic, R., Cvijanovic, O., Pugel, E.P., Zagorac, G.B., Mahmutefendic, H., Skoda, M., Luteolin ameliorates cisplatin-induced nephrotoxicity in mice through inhibition of platinum accumulation, inflammation and apoptosis in the kidney. Toxicology 310 (2013), 115–123.
23. Farzaei, M.H., Abbasabadi, Z., Ardekani, M.R., Rahimi, R., Farzaei, F., Parsley: a review of ethnopharmacology, phytochemistry and biological activities. J. Tradit. Chin. Med. 33 (2013), 815–826.
24. Ferrari, F.C., Ferreira, L.C., Souza, M.R., Grabe-Guimarães, A., Paula, C.A., Rezende, S.A., Saúde-Guimarães, D.A., Anti-Inflammatory sesquiterpene lactones from Lychnophora trichocarpha Spreng. (Brazilian arnica). Phytother. Res. 27 (2013), 384–389.
25. Funaro, A., Wu, X., Song, M., Zheng, J., Guo, S., Rakariyatham, K., Rodriguez-Estrada, M.T., Xiao, H., Enhanced anti-inflammatory activities by the combination of luteolin and tangeretin. J. Food Sci. 81 (2016), H1320–H1327.
26. Gautam, R., Jachak, S.M., Recent developments in anti-inflammatory natural products. Med. Res. Rev. 29 (2009), 767–820.
27. Goettert, M., Schattel, V., Koch, P., Merfort, I., Laufer, S., Biological evaluation and structural determinants of p38alpha mitogen-activated-protein kinase and c-Jun-N-terminal kinase 3 inhibition by flavonoids. Chembiochem 11 (2010), 2579–2588.
28. Griffith, J.W., Sokol, C.L., Luster, A.D., Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu. Rev. Immunol. 32 (2014), 659–702.
29. Guo, Y.F., Xu, N.N., Sun, W., Zhao, Y., Li, C.Y., Guo, M.Y., Luteolin reduces inflammation in Staphylococcus aureus-induced mastitis by inhibiting NF-κB activation and MMPs expression. Oncotarget 8 (2017), 28481–28493.
30. Hytti, M., Piippo, N., Korhonen, E., Honkakoski, P., Kaarniranta, K., Kauppinen, A., Fisetin and luteolin protect human retinal pigment epithelial cells from oxidative stress-induced cell death and regulate inflammation. Sci. Rep., 5, 2015, 17645.
31. Hytti, M., Szabo, D., Piippo, N., Korhonen, E., Honkakoski, P., Kaarniranta, K., Petrovski, G., Kauppinen, A., Two dietary polyphenols, fisetin and luteolin, reduce inflammation but augment DNA damage-induced toxicity in human RPE cells. J. Nutr. Biochem. 42 (2017), 37–42.
32. Ishihara, K., Hirano, T., Molecular basis of the cell specificity of cytokine action. Biochim. Biophys. Acta - Mol. Cell Res. 1592 (2002), 281–296.
33. Jasial, S., Hu, Y., Bajorath, J., How frequently are pan-assay interference compounds active? Large-scale analysis of screening data reveals diverse activity profiles, low global hit frequency, and many consistently inactive compounds. J. Med. Chem. 60 (2017), 3879–3886.
34. Jeon, I.H., Kim, H.S., Kang, H.J., Lee, H.S., Jeong, S.I., Kim, S.J., Jang, S.I., Anti-inflammatory and antipruritic effects of luteolin from Perilla (P. frutescens L.) leaves. Molecules 19 (2014), 6941–6951.
35. Jeong, D., Yi, Y.-S., Sung, G.-H., Yang, W.S., Park, J.G., Yoon, K., Yoon, D.H., Song, C., Lee, Y., Rhee, M.H., Kim, T.W., Kim, J.-H., Cho, J.Y., Anti-inflammatory activities and mechanisms of Artemisia asiatica ethanol extract. J. Ethnopharmacol. 152 (2014), 487–496.
36. Jia, Z., Nallasamy, P., Liu, D., Shah, H., Li, J.Z., Chitrakar, R., Si, H., McCormick, J., Zhu, H., Zhen, W., Li, Y., Luteolin protects against vascular inflammation in mice and TNF-alpha-induced monocyte adhesion to endothelial cells via suppressing IKappaBalpha/NF-kappaB signaling pathway. J. Nutr. Biochem. 26 (2015), 293–302.
37. Jin, M., Son, K.H., Chang, H.W., Luteolin-7-O-glucoside suppresses leukotriene C(4) production and degranulation by inhibiting the phosphorylation of mitogen activated protein kinases and phospholipase Cgamma1 in activated mouse bone marrow-derived mast cells. Biol. Pharm. Bull. 34 (2011), 1032–1036.
38. Jung, H.A., Jin, S.E., Min, B.S., Kim, B.W., Choi, J.S., Anti-inflammatory activity of Korean thistle Cirsium maackii and its major flavonoid, luteolin 5-O-glucoside. Food Chem. Toxicol. 50 (2012), 2171–2179.
39. Kanai, K., Nagata, S., Hatta, T., Sugiura, Y., Sato, K., Yamashita, Y., Kimura, Y., Itoh, N., Therapeutic anti-inflammatory effects of luteolin on endotoxin-induced uveitis in Lewis rats. J. Vet. Med. Sci. 78 (2016), 1381–1384.
40. Kang, O.-H., Choi, J.-G., Lee, J.-H., Kwon, D.-Y., Luteolin isolated from the flowers of Lonicera japonica suppresses inflammatory mediator release by blocking NF-κB and MAPKs activation pathways in HMC-1 Cells. Molecules 15 (2010), 385–398.
41. Kao, T.K., Ou, Y.C., Lin, S.Y., Pan, H.C., Song, P.J., Raung, S.L., Lai, C.Y., Liao, S.L., Lu, H.C., Chen, C.J., Luteolin inhibits cytokine expression in endotoxin/cytokine-stimulated microglia. J. Nutr. Biochem. 22 (2011), 612–624.
42. Katiyar, C., Gupta, A., Kanjilal, S., Katiyar, S., Drug discovery from plant sources: an integrated approach. Ayu 33 (2012), 10–19.
43. Kenneth, M.P. Taylor, 75-Day Premarket Notification of New Dietary Ingredients [Memorandum]. (January 16), 2003, Department of Health & Human Services: Public Health Service Food and Drug Administration (Retrieved from) 〈https://www.fda.gov/ohrms/dockets/dockets/95s0316/95s-0316-rpt0150-01-vol108.pdf〉.
44. Kim, E., Yoon, K.D., Lee, W.-S., Yang, W.S., Kim, S.H., Sung, N.Y., Baek, K.-S., Kim, Y., Htwe, K.M., Kim, Y.-D., Hong, S., Kim, J.-H., Cho, J.Y., Syk/Src-targeted anti-inflammatory activity of Codariocalyx motorius ethanolic extract. J. Ethnopharmacol. 155 (2014), 185–193.
45. Kim, H.J., Lee, W., Yun, J.M., Luteolin inhibits hyperglycemia-induced proinflammatory cytokine production and its epigenetic mechanism in human monocytes. Phytother. Res. 28 (2014), 1383–1391.
46. Kim, J.A., Kim, D.K., Kang, O.H., Choi, Y.A., Park, H.J., Choi, S.C., Kim, T.H., Yun, K.J., Nah, Y.H., Lee, Y.M., Inhibitory effect of luteolin on TNF-alpha-induced IL-8 production in human colon epithelial cells. Int. Immunopharmacol. 5 (2005), 209–217.
47. Kunle, O.F., Egharevba, H.O., Ahmadu, P.O., Standardization of herbal medicines - a review. Int. J. Biodivers. Conserv. 4 (2012), 101–112.
48. Kuo, M.Y., Liao, M.F., Chen, F.L., Li, Y.C., Yang, M.L., Lin, R.H., Kuan, Y.H., Luteolin attenuates the pulmonary inflammatory response involves abilities of antioxidation and inhibition of MAPK and NFkappaB pathways in mice with endotoxin-induced acute lung injury. Food Chem. Toxicol. 49 (2011), 2660–2666.
49. Kutil, Z., Temml, V., Maghradze, D., Pribylova, M., Dvorakova, M., Schuster, D., Vanek, T., Landa, P., Impact of wines and wine constituents on cyclooxygenase-1, cyclooxygenase-2, and 5-lipoxygenase catalytic activity. Mediat. Inflamm., 2014, 2014, 8.
50. Lamy, S., Moldovan, P.L., Ben Saad, A., Annabi, B., Biphasic effects of luteolin on interleukin-1beta-induced cyclooxygenase-2 expression in glioblastoma cells. Biochim. Biophys. Acta 1853 (2015), 126–135.
51. Lawrence, T., The nuclear factor NF-κB pathway in inflammation. Cold Spring Harb. Perspect. Biol., 1, 2009, a001651.
52. Lee, J.K., Kim, S.Y., Kim, Y.S., Lee, W.H., Hwang, D.H., Lee, J.Y., Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin. Biochem. Pharmacol. 77 (2009), 1391–1400.
53. Lee, J.O., Jeong, D., Kim, M.Y., Cho, J.Y., ATP-binding pocket-targeted suppression of Src and Syk by luteolin contributes to its anti-inflammatory action. Mediat. Inflamm., 2015, 2015, 967053.
54. Lee, J.P., Li, Y.C., Chen, H.Y., Lin, R.H., Huang, S.S., Chen, H.L., Kuan, P.C., Liao, M.F., Chen, C.J., Kuan, Y.H., Protective effects of luteolin against lipopolysaccharide-induced acute lung injury involves inhibition of MEK/ERK and PI3K/Akt pathways in neutrophils. Acta Pharmacol. Sin. 31 (2010), 831–838.
55. Lee, Y.S., Kim, M.S., Lee, D.H., Kwon, T.H., Song, H.H., Oh, S.R., Yoon, D.Y., Luteolin 8-C-beta-fucopyranoside downregulates IL-6 expression by inhibiting MAPKs and the NF-kappaB signaling pathway in human monocytic cells. Pharmacol. Rep. 67 (2015), 581–587.
56. Li, G., Liang, X., Lotze, M.T., HMGB1: the central cytokine for all lymphoid cells. Front Immunol., 4, 2013, 68.
57. Li, Y.C., Yeh, C.H., Yang, M.L., Kuan, Y.H., Luteolin suppresses inflammatory mediator expression by blocking the Akt/NFkappaB pathway in acute lung injury induced by lipopolysaccharide in mice. Evid. Based Complement. Altern. Med., 2012, 2012, 383608.
58. Liu, C.W., Lin, H.W., Yang, D.J., Chen, S.Y., Tseng, J.K., Chang, T.J., Chang, Y.Y., Luteolin inhibits viral-induced inflammatory response in RAW264.7 cells via suppression of STAT1/3 dependent NF-kappaB and activation of HO-1. Free Radic. Biol. Med. 95 (2016), 180–189.
59. Lopez-Lazaro, M., Distribution and biological activities of the flavonoid luteolin. Mini Rev. Med. Chem. 9 (2009), 31–59.
60. Lou, L., Liu, Y., Zhou, J., Wei, Y., Deng, J., Dong, B., Chai, L., Chlorogenic acid and luteolin synergistically inhibit the proliferation of interleukin-1beta-induced fibroblast-like synoviocytes through regulating the activation of NF-kappaB and JAK/STAT-signaling pathways. Immunopharmacol. Immunotoxicol. 37 (2015), 499–507.
61. Lu, X., Li, Y., Li, X., Aisa, H.A., Luteolin induces apoptosis in vitro through suppressing the MAPK and PI3K signaling pathways in gastric cancer. Oncol. Lett. 14 (2017), 1993–2000.
62. Lv, L., Lv, L., Zhang, Y., Kong, Q., Luteolin prevents LPS-induced TNF-α expression in cardiac myocytes through inhibiting NF-κB signaling pathway. Inflammation 34 (2011), 620–629.
63. Moura, D.S., Sultan, S., Georgin-Lavialle, S., Barete, S., Lortholary, O., Gaillard, R., Hermine, O., Evidence for cognitive impairment in mastocytosis: prevalence, features and correlations to depression. PLoS One, 7, 2012, e39468.
64. Nepali, S., Son, J.-S., Poudel, B., Lee, J.-H., Lee, Y.-M., Kim, D.-K., Luteolin is a bioflavonoid that attenuates adipocyte-derived inflammatory responses via suppression of nuclear factor-κB/mitogen-activated protein kinases pathway. Pharmacogn. Mag. 11 (2015), 627–635.
65. Nkengla, A., Investigation of the In Vitro Bioavailability of Luteolin from Modified Preparations of Artemisia afra. 2014, University of the Western Cape.
66. Nunes, C., Almeida, L., Barbosa, R.M., Laranjinha, J., Luteolin suppresses the JAK/STAT pathway in a cellular model of intestinal inflammation. Food Funct. 8 (2017), 387–396.
67. Ode, O.D., Asuzu, I.U., Luteolin isolate from the methanol extract identified as the single-carbon compound responsible for broad antiulcer activities of Cassia singueana Leaves. IOSR J. Pharm. 4 (2014), 17–23.
68. Oeckinghaus, A., Ghosh, S., The NF-κB family of transcription factors and its regulation. Cold Spring Harb. Perspect. Biol., 1, 2009, a000034.
69. Palombo, R., Savini, I., Avigliano, L., Madonna, S., Cavani, A., Albanesi, C., Mauriello, A., Melino, G., Terrinoni, A., Luteolin-7-glucoside inhibits IL-22/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model. Cell Death. Dis., 7, 2016, e2344.
70. Pandurangan, A.K., Esa, N.M., Luteolin, a bioflavonoid inhibits colorectal cancer through modulation of multiple signaling pathways: a review. Asian Pac. J. Cancer Prev. 15 (2014), 5501–5508.
71. Park, C.M., Jin, K.S., Lee, Y.W., Song, Y.S., Luteolin and chicoric acid synergistically inhibited inflammatory responses via inactivation of PI3K-Akt pathway and impairment of NF-kappaB translocation in LPS stimulated RAW 264.7 cells. Eur. J. Pharmacol. 660 (2011), 454–459.
72. Park, C.M., Park, J.Y., Noh, K.H., Shin, J.H., Song, Y.S., Taraxacum officinale Weber extracts inhibit LPS-induced oxidative stress and nitric oxide production via the NF-κB modulation in RAW 264.7 cells. J. Ethnopharmacol. 133 (2011), 834–842.
73. Park, C.M., Song, Y.S., Luteolin and luteolin-7-O-glucoside inhibit lipopolysaccharide-induced inflammatory responses through modulation of NF-kappaB/AP-1/PI3K-Akt signaling cascades in RAW 264.7 cells. Nutr. Res. Pract. 7 (2013), 423–429.
74. Parrella, E., Porrini, V., Iorio, R., Benarese, M., Lanzillotta, A., Mota, M., Fusco, M., Tonin, P., Spano, P., Pizzi, M., PEA and luteolin synergistically reduce mast cell-mediated toxicity and elicit neuroprotection in cell-based models of brain ischemia. Brain Res. 1648 (2016), 409–417.
75. Pohjala, L., Tammela, P., Aggregating behavior of phenolic compounds—a source of false bioassay results?. Molecules 17 (2012), 10774–10790.
76. Qiao, H., Zhang, X., Zhu, C., Dong, L., Wang, L., Zhang, X., Xing, Y., Wang, C., Ji, Y., Cao, X., Luteolin downregulates TLR4, TLR5, NF-kappaB and p-p38MAPK expression, upregulates the p-ERK expression, and protects rat brains against focal ischemia. Brain Res. 1448 (2012), 71–81.
77. Rafacho, B.P., Stice, C.P., Liu, C., Greenberg, A.S., Ausman, L.M., Wang, X.D., Inhibition of diethylnitrosamine-initiated alcohol-promoted hepatic inflammation and precancerous lesions by flavonoid luteolin is associated with increased sirtuin 1 activity in mice. Hepatobiliary Surg. Nutr. 4 (2015), 124–134.
78. Ramezani, M., Nasri, S., Yassa, N., Antinociceptive and anti-inflammatory effects of isolated fractions from Apium graveolens seeds in mice. Pharm. Biol. 47 (2009), 740–743.
79. Rasoanaivo, P., Wright, C.W., Willcox, M.L., Gilbert, B., Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions. Malar. J., 10(Suppl 1), 2011 (S4-S4).
80. Ribeiro, D., Freitas, M., Tomé S.M., Silva, A.M.S., Laufer, S., Lima, J.L.F.C., Fernandes, E., Flavonoids inhibit COX-1 and COX-2 enzymes and cytokine/chemokine production in human whole blood. Inflammation 38 (2015), 858–870.
81. Rostoka, E., Isajevs, S., Baumane, L., Line, A., Silina, K., Dzintare, M., Sharipova, J., Svirina, D., Kalvinsh, I., Sjakste, N., Effects of lycopene, indole-3-carbinol, and luteolin on nitric oxide production and iNOS expression are organ-specific in rats. Arh Hig Rada Toksikol. 61 (2010), 275–285.
82. Sae-wong, C., Tansakul, P., Tewtrakul, S., Anti-inflammatory mechanism of Kaempferia parviflora in murine macrophage cells (RAW 264.7) and in experimental animals. J. Ethnopharmacol. 124 (2009), 576–580.
83. Seelinger, G., Merfort, I., Schempp, C.M., Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta Med. 74 (2008), 1667–1677.
84. Serhan, C.N., Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators. J. Thromb. Haemost. 7 (2009), 44–48.
85. Sharma, J.N., Al-Omran, A., Parvathy, S.S., Role of nitric oxide in inflammatory diseases. Inflammopharmacology 15 (2007), 252–259.
86. Shi, F., Zhou, D., Ji, Z., Xu, Z., Yang, H., Anti-arthritic activity of luteolin in Freund's complete adjuvant-induced arthritis in rats by suppressing P2×4 pathway. Chem. Biol. Interact. 226 (2015), 82–87.
87. Silva, J.Bd, Mendes, Rd.F., Tomasco, V., Pinto, Nd.C.C., de Oliveira, L.G., Rodrigues, M.N., Aragão, D.Md.O., Aguiar, J.A.Kd, Alves, M.S., Castañon, M.C.N.M., Ribeiro, A., Scio, E., New aspects on the hepatoprotective potential associated with the antioxidant, hypocholesterolemic and anti-inflammatory activities of Vernonia condensata Baker. J. Ethnopharmacol. 198 (2017), 399–406.
88. Son, Y., Cheong, Y.-K., Kim, N.-H., Chung, H.-T., Kang, D.G., Pae, H.-O., Mitogen-activated protein kinases and reactive oxygen species: how can ROS activate MAPK pathways?. J. Signal. Transduct., 2011, 2011, 6.
89. Song, S., Su, Z., Xu, H., Niu, M., Chen, X., Min, H., Zhang, B., Sun, G., Xie, S., Wang, H., Gao, Q., Luteolin selectively kills STAT3 highly activated gastric cancer cells through enhancing the binding of STAT3 to SHP-1. Cell Death. Dis., 8, 2017, e2612.
90. Sung, J., Lee, J., Anti-inflammatory activity of butein and luteolin through suppression of NFkappaB activation and induction of heme oxygenase-1. J. Med. Food 18 (2015), 557–564.
91. Taliou, A., Zintzaras, E., Lykouras, L., Francis, K., An open-label pilot study of a formulation containing the anti-inflammatory flavonoid luteolin and its effects on behavior in children with autism spectrum disorders. Clin. Ther. 35 (2013), 592–602.
92. Theoharides, T.C., Asadi, S., Panagiotidou, S., A case series of a luteolin formulation (NeuroProtek(R)) in children with autism spectrum disorders. Int. J. Immunopathol. Pharmacol. 25 (2012), 317–323.
93. Thitilertdecha, P., Guy, R.H., Rowan, M.G., Characterisation of polyphenolic compounds in Clerodendrum petasites S. Moore and their potential for topical delivery through the skin. J. Ethnopharmacol. 154 (2014), 400–407.
94. Tsilioni, I., Taliou, A., Francis, K., Theoharides, T.C., Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6. Transl. Psychiatry, 5, 2015, e647.
95. Tuorkey, M.J., Molecular targets of luteolin in cancer. Eur. J. Cancer Prev. 25 (2016), 65–76.
96. Turner, M.D., Nedjai, B., Hurst, T., Pennington, D.J., Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. Biochim. Biophys. Acta 1843 (2014), 2563–2582.
97. Wall, C., Lim, R., Poljak, M., Lappas, M., Dietary flavonoids as therapeutics for preterm birth: luteolin and kaempferol suppress inflammation in human gestational tissues in vitro. Oxid. Med. Cell Longev., 2013, 2013, 485201.
98. Wright, B., Watson, K.A., McGuffin, L.J., Lovegrove, J.A., Gibbins, J.M., GRID and docking analyses reveal a molecular basis for flavonoid inhibition of Src family kinase activity. J. Nutr. Biochem. 26 (2015), 1156–1165.
99. Wu, J., Xu, X., Li, Y., Kou, J., Huang, F., Liu, B., Liu, K., Quercetin, luteolin and epigallocatechin gallate alleviate TXNIP and NLRP3-mediated inflammation and apoptosis with regulation of AMPK in endothelial cells. Eur. J. Pharmacol. 745 (2014), 59–68.
100. Wu, W., Li, D., Zong, Y., Zhu, H., Pan, D., Xu, T., Wang, T., Wang, T., Luteolin inhibits inflammatory responses via p38/MK2/TTP-mediated mRNA stability. Molecules 18 (2013), 8083–8094.
101. Xia, F., Wang, C., Jin, Y., Liu, Q., Meng, Q., Liu, K., Sun, H., Luteolin protects HUVECs from TNF-alpha-induced oxidative stress and inflammation via its effects on the Nox4/ROS-NF-kappaB and MAPK pathways. J. Atheroscler. Thromb. 21 (2014), 768–783.
102. Xia, N., Chen, G., Liu, M., Ye, X., Pan, Y., Ge, J., Mao, Y., Wang, H., Wang, J., Xie, S., Anti-inflammatory effects of luteolin on experimental autoimmune thyroiditis in mice. Exp. Ther. Med. 12 (2016), 4049–4054.
103. Xiong, J., Wang, K., Yuan, C., Xing, R., Ni, J., Hu, G., Chen, F., Wang, X., Luteolin protects mice from severe acute pancreatitis by exerting HO-1-mediated anti-inflammatory and antioxidant effects. Int. J. Mol. Med. 39 (2017), 113–125.
104. Xu, J., Wang, H., Lu, X., Ding, K., Zhang, L., He, J., Wei, W., Wu, Y., Posttraumatic administration of luteolin protects mice from traumatic brain injury: implication of autophagy and inflammation. Brain Res. 1582 (2014), 237–246.
105. Xu, Y., Zhang, J., Liu, J., Li, S., Li, C., Wang, W., Ma, R., Liu, Y., Luteolin attenuate the D-galactose-induced renal damage by attenuation of oxidative stress and inflammation. Nat. Prod. Res. 29 (2015), 1078–1082.
106. Yang, W.S., Kim, D., Yi, Y.-S., Kim, J.H., Jeong, H.Y., Hwang, K., Kim, J.-H., Park, J., Cho, J.Y., AKT-targeted anti-inflammatory activity of the methanol extract of Chrysanthemum indicum var. albescens. J. Ethnopharmacol. 201 (2017), 82–90.
107. Yasuda, M.T., Fujita, K., Hosoya, T., Imai, S., Shimoi, K., Absorption and metabolism of luteolin and its glycosides from the extract of Chrysanthemum morifolium flowers in rats and Caco-2 cells. J. Agric. Food Chem. 63 (2015), 7693–7699.
108. Yu, D., Li, M., Tian, Y., Liu, J., Shang, J., Luteolin inhibits ROS-activated MAPK pathway in myocardial ischemia/reperfusion injury. Life Sci. 122 (2015), 15–25.
109. Yu, T., Yang, Y., Kwak, Y.S., Song, G.G., Kim, M.Y., Rhee, M.H., Cho, J.Y., Ginsenoside Rc from Panax ginseng exerts anti-inflammatory activity by targeting TANK-binding kinase 1/interferon regulatory factor-3 and p38/ATF-2. J. Ginseng Res. 41 (2017), 127–133.
110. Zeng, P., Zhang, Y., Pan, C., Jia, Q., Guo, F., Li, Y., Zhu, W., Chen, K., Advances in studying of the pharmacological activities and structure–activity relationships of natural C-glycosylflavonoids. Acta Pharm. Sin. B. 3 (2013), 154–162.
111. Zhang, J.X., Xing, J.G., Wang, L.L., Jiang, H.L., Guo, S.L., Liu, R., Luteolin inhibits fibrillary beta-amyloid1-40-induced inflammation in a human blood-brain barrier model by suppressing the p38 MAPK-mediated NF-kappaB signaling pathways. (22) Molecules, 22(3), 2017, E334, 10.3390/molecules22030334.
112. Zhou, F., Qu, L., Lv, K., Chen, H., Liu, J., Liu, X., Li, Y., Sun, X., Luteolin protects against reactive oxygen species-mediated cell death induced by zinc toxicity via the PI3K-Akt-NF-kappaB-ERK-dependent pathway. J. Neurosci. Res. 89 (2011), 1859–1868.
113. Zhou, P., Li, L.-P., Luo, S.-Q., Jiang, H.-D., Zeng, S., Intestinal absorption of luteolin from peanut hull extract is more efficient than that from individual pure luteolin. J. Agric. Food Chem. 56 (2008), 296–300.
114. Zhu, L., Chen, J., Tan, J., Liu, X., Wang, B., Flavonoids from Agrimonia pilosa Ledeb: free radical scavenging and DNA oxidative damage protection activities and analysis of bioactivity-structure relationship based on molecular and electronic structures. Molecules, 22, 2017, E195, 10.3390/molecules22030195.
115. Zhu, L.H., Bi, W., Qi, R.B., Wang, H.D., Lu, D.X., Luteolin inhibits microglial inflammation and improves neuron survival against inflammation. Int. J. Neurosci. 121 (2011), 329–336.